Pati Aji Achdiat, Oki Suwarsa, Yudi Mulyana Hidayat, Mohamad Nasir Shafiee, Reiva Farah Dwiyana, Reti Hindritiani, Endang Sutedja, Satiti Retno Pudjiati, Dany Hilmanto, Meita Dhamayanti, Ida Parwati, Retno Hesty Maharani, Eva Krishna Sutedja, Erda Avriyanti, Yunitasari
INTRODUCTION: Various treatments available today for anogenital and cutaneous warts have limitations, including time-consuming, challenging to perform, and the risk of scarring. A new treatment using tuberculin purified protein derivative (PPD) has been developed, which is expected to generate cellular immunity against HPV. OBJECTIVE: To assess the evidence for the efficacy and safety of PPD treatment for cutaneous and anogenital warts. MATERIALS AND METHODS: A literature search was performed with the keyword-based search on digital libraries, including the National Library of Medicine, Cochrane Controlled Register of Trial, and Google Scholar, using the following terms: anogenital warts, condyloma acuminata, cutaneous warts, human papillomavirus, immunotherapy, and tuberculin purified protein derivative...
2024: ImmunoTargets and Therapy